This course has expired. View available courses.
Infectious Disease
Eliminating Hepatitis C by 2030: what’s stigma got to do with it?
Chronic hepatitis C (HCV) treatment is still not reaching many Australians despite the introduction of curative direct-acting antiviral agents here in 2016. It is estimated that 129,640 are still living with HCV. If left untreated, at least 25% of these cases will develop cirrhosis, and many will progress to end-stage liver disease and liver cancer.
Why are these people not presenting for treatment? Stigma still represents a key barrier to diagnosis and treatment. Australia’s Fifth National Hepatitis C Strategy 2018–2022 has identified stigma and discrimination as one of five key priority areas for action. This podcast aims to empower GPs to recognise the different ways in which stigma related to HCV infection can present in the primary care setting and consider communication techniques and tools to help overcome this – thereby optimising outcomes for patients with HCV infection.
This program is supported by an independent educational grant provided from Gilead.
DURATION
30 mins
PROFESSION
Physician, Nursing
# OF CREDITS
0
ACCREDITATION
Unaccredited
EXPIRY DATE
2022-12-31
Chronic hepatitis C (HCV) treatment is still not reaching many Australians despite the introduction of curative direct-acting antiviral agents here in 2016. It is estimated that 129,640 are still living with HCV. If left untreated, at least 25% of these cases will develop cirrhosis, and many will progress to end-stage liver disease and liver cancer.
Why are these people not presenting for treatment? Stigma still represents a key barrier to diagnosis and treatment. Australia’s Fifth National Hepatitis C Strategy 2018–2022 has identified stigma and discrimination as one of five key priority areas for action. This podcast aims to empower GPs to recognise the different ways in which stigma related to HCV infection can present in the primary care setting and consider communication techniques and tools to help overcome this – thereby optimising outcomes for patients with HCV infection.
This program is supported by an independent educational grant provided from Gilead.
Faculty
Dr Annie Balcomb
Dr Nada Andric
Learning objectives
After listening to this podcast, GP's will be able to:
- Recognise the different ways in which stigma related to HCV infection can present in the primary care setting
- Describe the ways in which stigma can have a negative impact on outcomes for patients with HCV infection
- Understand the ways in which addressing stigma in primary care can help achieve the goal of eliminating HCV by 2030
- Reflect on how stigma associated with HCV infection can be proactively mitigated in everyday practice
#
of credits: 0
Duration: 30 mins
FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
30 mins
Duration
Physician, Nursing
Profession
0
# of credits
Learning Objectives
After listening to this podcast, GP’s will be able to:
- Recognise the different ways in which stigma related to HCV infection can present in the primary care setting
- Describe the ways in which stigma can have a negative impact on outcomes for patients with HCV infection
- Understand the ways in which addressing stigma in primary care can help achieve the goal of eliminating HCV by 2030
- Reflect on how stigma associated with HCV infection can be proactively mitigated in everyday practice
Unaccredited
ACCREDITATION
Infectious Disease
Learning Category
Hepatitis C
Topic
0
Price
2022-12-31
Expiry Date
AUS
Region/Language
Course Description
Chronic hepatitis C (HCV) treatment is still not reaching many Australians despite the introduction of curative direct-acting antiviral agents here in 2016. It is estimated that 129,640 are still living with HCV. If left untreated, at least 25% of these cases will develop cirrhosis, and many will progress to end-stage liver disease and liver cancer.
Why are these people not presenting for treatment? Stigma still represents a key barrier to diagnosis and treatment. Australia’s Fifth National Hepatitis C Strategy 2018–2022 has identified stigma and discrimination as one of five key priority areas for action. This podcast aims to empower GPs to recognise the different ways in which stigma related to HCV infection can present in the primary care setting and consider communication techniques and tools to help overcome this – thereby optimising outcomes for patients with HCV infection.
This program is supported by an independent educational grant provided from Gilead.
Faculty
Dr Annie Balcomb
Dr Nada Andric
Accreditation
30 mins
Duration
0
Price
0
# of credits
